Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House

WASHINGTON, D.C. - Today, Chairman Rick Scott's bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act received bicameral support with Congressman Rich McCormick leading the effort in the House of Representatives. While many prescription drugs, and their active pharmaceutical ingredients (APIs), are manufactured overseas, particularly in Communist China and India, current federal labeling requirements do not require public disclosure of where those ingredients or finished products are made. The CLEAR LABELS Act would require prescription drug labels to disclose the original manufacturers of prescription drugs and APIs to ensure patients, providers, and regulators have clear, upfront information about where the drugs they rely on day after day are made.

This legislation builds on bipartisan efforts led by Chairman Scott, including an investigative report and more than a dozen inquiries to federal agencies and industry leaders requesting information on the U.S.'s dangerous overreliance on foreign-manufactured generic drugs.

Ranking Member Kirsten Gillibrand and Senators Ron Johnson, Tommy Tuberville, and Katie Britt are cosponsors in the U.S. Senate.

Chairman Rick Scott said, "As parents and grandparents, we do everything we can to make informed, safe decisions that keep our families safe and healthy. But right now, families are kept in the dark about where the drugs they rely on are coming from. America's drug supply is dependent on our adversaries like Communist China and nations such as India to manufacture our drugs and their ingredients, often with limited transparency and oversight. This broken process leaves patients clueless about where their drugs come from. Families deserve to have confidence that the medicines they take are safe, regulated, and clearly labeled. That's why I'm leading the bipartisan, and now bicameral, CLEAR LABELS Act to ensure your medicines have clear and upfront country-of-origin labeling to help ensure every American can feel comfortable knowing what's in their medicine cabinet. I appreciate my colleagues in the Senate for joining me in this effort, and I'm thankful to Congressman McCormick for leading the way in the House."

Congressman Rich McCormick said, "I'm proud to be the House co-lead of the CLEAR LABELS Act. This bicameral bill will bring transparency to consumers, pharmacists, providers, and purchasers about the country of origin of pharmaceuticals and APIs and empower stakeholders with knowledge of where their medications come from. Americans deserve to know where their prescription drugs, or the active pharmaceutical ingredients (APIs) used to make them, are manufactured. I'm proud to work alongside Sen. Rick Scott to pass this legislation."

###